- Grew Net Sales to $336.9 Million, Up 10% from Q3 2021
- Secured Up to $125 Million in Available Debt for Large Capital-Intensive Programs
SACRAMENTO, Calif,, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, reported its financial results for the quarter ended September 30, 2022.
“Focused on long-term growth, we created the financial flexibility to accelerate the next phase of our capital expenditure program, which will build upon strategic repairs and maintenance completed in 2022,” said Mike Kandris, CEO of Alto Ingredients. “Year-to-date, we successfully upgraded equipment and operating systems to increase plant efficiency, reliability, redundancy, and capacity. Regardless, and as expected, our third quarter 2022 results were affected by logistical constraints, increased transportation costs, and low commodity margins. With proceeds from our announced $125 million term debt financing, we will implement larger capital-intensive growth projects to further our specialty alcohols and essential ingredients diversification strategy, minimize the impact of commodity pricing volatility and enrich our margin profile. Opportunities under evaluation include carbon capture sequestration, yeast production, energy supply improvements and more. We are excited about the future and look forward to delivering additional value to all our stakeholders.”
Financial Results for the Three Months Ended September 30, 2022 Compared to 2021
- Net sales were $336.9 million, compared to $305.6 million.
- Cost of goods sold was $356.7 million, compared to $309.0 million.
- Gross loss was $19.8 million, compared to $3.4 million.
- Selling, general and administrative expenses were $7.4 million, compared to $5.5 million, reflecting Eagle Alcohol acquisition-related expenses and higher stock-compensation expenses in the third quarter of 2022.
- Net loss available to common stockholders was $28.4 million, or $0.39 per share, compared to $3.5 million, or $0.05 per share.
- Adjusted EBITDA was negative $20.6 million, compared to Adjusted EBITDA of $3.0 million.
- Cash and cash equivalents were $28.5 million at September 30, 2022, compared to $50.6 million at December 31, 2021. Subsequent to quarter end, the company entered into a new six-year term loan facility allowing for periodic draws in an aggregate amount of up to $125 million.
- Working capital was $131.8 million at September 30, 2022, compared to $159.9 million at December 31, 2021. During the quarter, the company repurchased approximately 250,000 shares of its common stock for $1.0 million.
Third Quarter 2022 Results Conference Call
Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Monday, November 7, 2022, and will deliver prepared remarks via webcast followed by a question-and-answer session.
The webcast for the call can be accessed from Alto Ingredients’ website at www.altoingredients.com. Alternatively, you may register for the conference by navigating to https://dpregister.com/sreg/10170909/f454bd37e8 to receive a number and unique PIN by email or you may dial the following number up to twenty minutes prior to the scheduled conference call time: (833) 630-0017. Internationally please call (412) 317-1806. Please ask to join the Alto Ingredients call.
The webcast will be archived for replay on Alto Ingredients’ website for one year. In addition, a telephonic replay will be available at 8:00 p.m. Eastern Time on Monday, November 7, 2022, through 8:00 p.m. Eastern Time on Monday, November 14, 2022. To access the replay, please dial 877-344-7529. International callers should dial 00-1 412-317-0088. The pass code will be 6007653.
Use of Non-GAAP Measures
Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited net income (loss) before interest expense, interest income, provision for income taxes, asset impairments, loss on extinguishment of debt, acquisition-related expense, fair value adjustments, and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.
About Alto Ingredients, Inc.
Alto Ingredients, Inc. (ALTO) is a leading producer and distributor of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information, please visit www.altoingredients.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ near- and long-term outlook; its capital projects and business strategy, and their outcomes and effects; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; the cost, timing and effects of, including the financial results deriving from, Alto Ingredients’ capital improvement projects; and the effects of the coronavirus pandemic, and its resurgence or abatement, and governmental, business and consumer responses to the pandemic. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 9, 2022.
Media Contact:
Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com
Company IR Contact:
Michael Kramer, Alto Ingredients, Inc., 916-403-2755, investorrelations@altoingredients.com
IR Agency Contact:
Kirsten Chapman, LHA Investor Relations, 415-433-3777, investorrelations@altoingredients.com
ALTO INGREDIENTS, INC
ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
| Net sales |
$ |
336,877 |
|
$ |
305,556 |
|
|
$ |
1,007,184 |
|
$ |
822,400 |
|
| Cost of goods sold |
|
356,716 |
|
|
308,955 |
|
|
|
1,013,406 |
|
|
796,729 |
|
| Gross profit (loss) |
|
(19,839 |
) |
|
(3,399 |
) |
|
|
(6,222 |
) |
|
25,671 |
|
| Selling, general and administrative expenses |
|
(7,403 |
) |
|
(5,533 |
) |
|
|
(24,028 |
) |
|
(19,777 |
) |
| Asset impairments |
|
— |
|
|
— |
|
|
|
— |
|
|
(3,100 |
) |
| Income (loss) from operations |
|
(27,242 |
) |
|
(8,932 |
) |
|
|
(30,250 |
) |
|
2,794 |
|
| Interest expense, net |
|
(340 |
) |
|
(429 |
) |
|
|
(859 |
) |
|
(3,359 |
) |
| Income from loan forgiveness |
|
— |
|
|
5,973 |
|
|
|
— |
|
|
9,860 |
|
| Income from cash grant |
|
— |
|
|
— |
|
|
|
22,652 |
|
|
— |
|
| Other income (expense), net |
|
(456 |
) |
|
256 |
|
|
|
(68 |
) |
|
641 |
|
| Income (loss) before provision for income taxes |
|
(28,038 |
) |
|
(3,132 |
) |
|
|
(8,525 |
) |
|
9,936 |
|
| Provision for income taxes |
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
| Net income (loss) |
$ |
(28,038 |
) |
$ |
(3,132 |
) |
|
$ |
(8,525 |
) |
$ |
9,936 |
|
| Preferred stock dividends |
$ |
(319 |
) |
$ |
(319 |
) |
|
$ |
(946 |
) |
$ |
(946 |
) |
| Income allocated to participating securities |
|
— |
|
|
— |
|
|
|
— |
|
|
(120 |
) |
| Net income (loss) available to common stockholders |
$ |
(28,357 |
) |
$ |
(3,451 |
) |
|
$ |
(9,471 |
) |
$ |
8,870 |
|
| Net income (loss) per share, basic |
$ |
(0.39 |
) |
$ |
(0.05 |
) |
|
$ |
(0.13 |
) |
$ |
0.12 |
|
| Net income (loss) per share, diluted |
$ |
(0.39 |
) |
$ |
(0.05 |
) |
|
$ |
(0.13 |
) |
$ |
0.12 |
|
| Weighted-average shares outstanding, basic |
|
73,011 |
|
|
71,383 |
|
|
|
71,815 |
|
|
71,002 |
|
| Weighted-average shares outstanding, diluted |
|
73,011 |
|
|
71,383 |
|
|
|
71,815 |
|
|
72,260 |
|
ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)
|
September 30, |
|
December 31, |
| ASSETS |
2022 |
|
2021 |
| Current Assets: |
|
|
| Cash and cash equivalents |
$ |
28,458 |
|
$ |
50,612 |
| Restricted cash |
|
3,955 |
|
|
11,513 |
| Accounts receivable, net |
|
76,455 |
|
|
86,888 |
| Inventories |
|
61,088 |
|
|
54,373 |
| Derivative instruments |
|
7,384 |
|
|
15,839 |
| Other current assets |
|
8,966 |
|
|
10,301 |
| Total current assets |
|
186,306 |
|
|
229,526 |
| Property and equipment, net |
|
233,475 |
|
|
222,550 |
| Other Assets: |
|
|
| Right of use operating lease assets, net |
|
12,895 |
|
|
13,413 |
| Notes receivable, noncurrent |
|
— |
|
|
11,641 |
| Intangible assets, net |
|
9,234 |
|
|
2,678 |
| Goodwill |
|
5,970 |
|
|
— |
| Other assets |
|
6,788 |
|
|
5,145 |
| Total other assets |
|
34,887 |
|
|
32,877 |
| Total Assets |
$ |
454,668 |
|
$ |
484,953 |
ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)
|
September 30, |
|
|
December 31, |
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
2022
|
|
|
2021 |
|
| Current Liabilities: |
|
|
| Accounts payable – trade |
$ |
17,493 |
|
|
$ |
23,251 |
|
| Accrued liabilities |
|
22,172 |
|
|
|
21,307 |
|
| Current portion – operating leases |
|
3,646 |
|
|
|
3,909 |
|
| Derivative instruments |
|
1,106 |
|
|
|
13,582 |
|
| Other current liabilities |
|
10,096 |
|
|
|
7,553 |
|
| Total current liabilities |
|
54,513 |
|
|
|
69,602 |
|
|
|
|
| Long-term debt |
|
45,888 |
|
|
|
50,361 |
|
| Operating leases, net of current portion |
|
9,201 |
|
|
|
9,382 |
|
| Other liabilities |
|
10,068 |
|
|
|
10,394 |
|
| Total Liabilities |
|
119,670 |
|
|
|
139,739 |
|
|
|
|
| Stockholders’ Equity: |
|
|
| Alto Ingredients, Inc. Stockholders’ Equity: |
|
|
Preferred stock, $0.001 par value; 10,000 shares authorized;
Series A: 0 shares issued and outstanding as of
September 30, 2022 and December 31, 2021
Series B: 927 shares issued and outstanding as of
September 30, 2022 and December 31, 2021 |
|
1 |
|
|
|
1 |
|
| Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively |
|
74 |
|
|
|
73 |
|
| Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021 |
|
— |
|
|
|
— |
|
| Additional paid-in capital |
|
1,036,459 |
|
|
|
1,037,205 |
|
| Accumulated other comprehensive loss |
|
(284 |
) |
|
|
(284 |
) |
| Accumulated deficit |
|
(701,252 |
) |
|
|
(691,781 |
) |
| Total Stockholders’ Equity |
|
334,998 |
|
|
|
345,214 |
|
| Total Liabilities and Stockholders’ Equity |
$ |
454,668 |
|
|
$ |
484,953 |
|
Reconciliation of Adjusted EBITDA to Net Income (Loss)
|
Three Months Ended
September 30, |
|
|
Nine Months Ended
September 30, |
|
| (in thousands) (unaudited) |
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
2021 |
|
| Net income (loss) |
$ |
(28,038 |
) |
$ |
(3,132 |
) |
|
$ |
(8,525 |
) |
$ |
9,936 |
|
| Adjustments: |
|
|
|
|
| Interest expense |
|
340 |
|
|
429 |
|
|
|
859 |
|
|
3,359 |
|
| Interest income |
|
(38 |
) |
|
(183 |
) |
|
|
(341 |
) |
|
(553 |
) |
| Asset impairments |
|
— |
|
|
— |
|
|
|
— |
|
|
3,100 |
|
| Acquisition-related expense |
|
875 |
|
|
— |
|
|
|
2,625 |
|
|
— |
|
| Provision for income taxes |
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
| Depreciation and amortization expense |
|
6,260 |
|
|
5,851 |
|
|
|
19,122 |
|
|
17,520 |
|
| Total adjustments |
|
7,437 |
|
|
6,097 |
|
|
|
22,265 |
|
|
23,426 |
|
| Adjusted EBITDA |
$ |
(20,601 |
) |
$ |
2,965 |
|
|
$ |
13,740 |
|
$ |
33,362 |
|
Commodity Price Performance
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
| (unaudited) |
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
2021 |
|
| Renewable fuel production gallons sold (in millions) |
|
53.0 |
|
|
38.3 |
|
|
|
153.4 |
|
|
118.6 |
|
| Specialty alcohol production gallons sold (in millions) |
|
23.3 |
|
|
19.7 |
|
|
|
72.4 |
|
|
63.1 |
|
| Third party renewable fuel gallons sold (in millions) |
|
27.6 |
|
|
67.2 |
|
|
|
88.4 |
|
|
180.5 |
|
| Total gallons sold (in millions) |
|
103.9 |
|
|
125.2 |
|
|
|
314.2 |
|
|
362.2 |
|
|
|
|
|
|
| Total gallons produced (in millions) |
|
74.7 |
|
|
60.6 |
|
|
|
226.0 |
|
|
182.2 |
|
|
|
|
|
|
| Production capacity utilization |
|
85 |
% |
|
59 |
% |
|
|
86 |
% |
|
57 |
% |
|
|
|
|
|
| Average sales price per gallon |
$ |
2.70 |
|
$ |
2.47 |
|
|
$ |
2.66 |
|
$ |
2.27 |
|
|
|
|
|
|
| Average CBOT ethanol price per gallon |
$ |
2.16 |
|
$ |
2.25 |
|
|
$ |
2.16 |
|
$ |
2.08 |
|
|
|
|
|
|
| Corn cost per bushel – CBOT equivalent |
$ |
7.27 |
|
$ |
6.09 |
|
|
$ |
6.98 |
|
$ |
5.71 |
|
| Average basis |
|
1.08 |
|
|
0.89 |
|
|
|
0.80 |
|
|
0.53 |
|
| Delivered cost of corn |
$ |
8.35 |
|
$ |
6.98 |
|
|
$ |
7.78 |
|
$ |
6.24 |
|
|
|
|
|
|
| Total essential ingredients tons sold (in thousands) |
|
422.0 |
|
|
305.6 |
|
|
|
1,234.9 |
|
|
886.5 |
|
| Essential ingredients revenues as % of delivered cost of corn |
|
30.4 |
% |
|
29.5 |
% |
|
|
33.2 |
% |
|
|
33.8 |
% |
|
Segment Financials
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Net sales |
|
|
|
|
|
|
Pekin Campus production, recorded as gross: |
|
|
|
|
|
|
| Alcohol sales |
$ |
133,680 |
|
$ |
114,587 |
|
$ |
393,498 |
|
$ |
341,967 |
|
| Essential ingredient sales |
|
54,537 |
|
|
46,016 |
|
|
169,670 |
|
|
140,670 |
|
| Intersegment sales |
|
332 |
|
|
293 |
|
|
857 |
|
|
919 |
|
| Total Pekin Campus sales |
|
188,549 |
|
|
160,896 |
|
|
564,025 |
|
|
483,556 |
|
Marketing and distribution: |
|
|
|
|
|
|
|
|
|
|
|
|
| Alcohol sales, gross |
$ |
55,262 |
|
$ |
112,393 |
|
$ |
172,746 |
|
$ |
255,702 |
|
| Alcohol sales, net |
|
308 |
|
|
505 |
|
|
975 |
|
|
1,489 |
|
| Intersegment sales |
|
3,121 |
|
|
2,415 |
|
|
9,360 |
|
|
7,277 |
|
| Total marketing and distribution sales |
|
58,691 |
|
|
115,313 |
|
|
183,081 |
|
|
264,468 |
|
|
|
|
|
|
|
|
| Other production, recorded as gross: |
|
|
|
|
|
|
| Alcohol sales |
$ |
64,492 |
|
$ |
25,188 |
|
$ |
191,483 |
|
$ |
63,311 |
|
| Essential ingredient sales |
|
24,439 |
|
|
6,867 |
|
|
66,748 |
|
|
19,261 |
|
| Intersegment sales |
|
3 |
|
|
259 |
|
|
14 |
|
|
896 |
|
| Total Other production sales |
|
88,934 |
|
|
32,314 |
|
|
258,245 |
|
|
83,468 |
|
| Corporate and other |
|
4,159 |
|
|
— |
|
|
12,064 |
|
|
— |
|
| Intersegment eliminations |
|
(3,456 |
) |
|
(2,967 |
) |
|
(10,231 |
) |
|
(9,092 |
) |
| Net sales as reported |
$ |
336,877 |
|
$ |
305,556 |
|
$ |
1,007,184 |
|
$ |
822,400 |
|
| Cost of goods sold: |
|
|
|
|
|
|
|
|
|
|
|
|
| Pekin Campus |
$ |
207,939 |
|
$ |
169,720
|
|
$ |
572,512 |
|
$ |
468,970 |
|
| Marketing and distribution |
55,159
|
|
|
105,903
|
|
|
173,670 |
|
|
245,606 |
|
| Other production |
91,663
|
|
|
35,613
|
|
|
261,514 |
|
|
87,055 |
|
| Corporate and other |
2,925
|
|
|
—
|
|
|
8,995 |
|
|
— |
|
| Intersegment eliminations |
(970
|
) |
|
(2,281 |
) |
|
(3,285 |
) |
|
(4,902 |
) |
| Cost of goods sold as reported |
$ |
356,716 |
|
$ |
308,955
|
|
$ |
1,013,406
|
|
$ |
796,729 |
|
| Gross profit (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pekin Campus |
$ |
(19,390 |
) |
$ |
(8,824 |
) |
$ |
(8,487 |
) |
$ |
14,586 |
|
|
| Marketing and distribution |
|
3,532 |
|
|
9,410 |
|
|
9,411 |
|
|
18,862 |
|
|
| Other production |
|
(2,729 |
) |
|
(3,299 |
) |
|
(3,269 |
) |
|
(3,587 |
) |
|
| Corporate and other |
|
1,234 |
|
|
— |
|
|
3,069 |
|
|
— |
|
|
| Intersegment eliminations |
|
(2,486 |
) |
|
(686 |
) |
|
(6,946 |
) |
|
(4,190 |
) |
|
| Gross profit (loss) as reported |
$ |
(19,839 |
) |
$ |
(3,399 |
) |
$ |
(6,222 |
) |
$ |
25,671 |
|
|
